News

First Empirical Evidence of Collagen Damage during Bone Fracture

  Bone is a remarkable material, strong enough to withstand impressive forces without fracturing. Despite decades of research, however, our understanding of the molecular mechanisms underlying bone’s fracture resistance has remained incomplete. It has long been hypothesized that collagen degradation occurs following bone fracture. Until recently, this hypothesis lacked empirical evidence due to a...
View Details

Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease

  Chronic kidney disease (CKD) progressively impairs kidney function, affecting millions. Beyond kidney-related complications, patients often experience muscle weakness and reduced mobility, begging the question: does muscle fibrosis contribute to those limitations? Figure 1 demonstrates a significant increase in collagen deposition within the vastus lateralis muscle of CKD patients. Histochemical analysis using picro-sirius red...
View Details

Advancing Intervertebral Disc Degeneration Assessment with Collagen Hybridizing peptides: A Fast, Accurate Approach for Research and Clinical Applications

     Intervertebral disc (IVD) degeneration is a significant contributor to lower back pain, a leading cause of disability in individuals over 45. IVD is marked by the degradation of collagen and the extracellular matrix, which triggers inflammatory responses, recruits macrophages, and accelerates degeneration. Monitoring the progression of IVD degeneration and assessing the effectiveness...
View Details

Collagen Hybridizing Peptides Conjugated to Water-Soluble Copolymers for Targeting Intratibial Osteosarcoma

Discover innovative strategies for treating osteosarcoma (OS) with localized drug delivery using Collagen Hybridizing Peptides (CHPs). OS, a malignant bone cancer, often requires surgery and chemotherapy, but these treatments are plagued by systemic side effects. This research highlights the potential of CHPs to selectively target tumors by binding to damaged collagen in bone tissue.
View Details